Eligible patients had suspected or laboratory confirmed SARS-CoV-2 infection and were considered to be at low risk for negative effects of steroid use

Online case report form to record patient status, eligibility for treatment, and treatment availability

Patients assigned to standard care or DEX treatment at 2:1 ratio

If DEX wasn’t available or a physician determined it wasn’t suitable for a patient, they were not given the drug and were removed from study data

Patients were given 6 mg/day of DEX for 10 days or until death/discharge

Adherence to treatment and details about course of illness and/or cause of death were recorded for all participants through another online form